-
-
-
-
-
-
-
Eledon Pharmaceuticals, Inc. (ELDN) Misses Q1 EPS by 15c
-
-
-
-
-
-
-
Eledon completes $57.5 million financing to advance drug trials
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Eledon Pharamceuticals (ELDN)
-
-
-
-
-
-
-
Eledon Pharmaceuticals, Inc. (ELDN) Reports In-Line Q3 EPS
-
-
-
458,204 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

